Katarzyna Jastrzębska, Agata Szymańska, Tomasz Pawlak and Rafał Dolot
Org. Biomol. Chem., 2025,23, 8755-8763
Abstract
We demonstrate the oxathiaphospholane-based synthesis of novel P-stereodefined phosphorothioate N-modified morpholino analogs with confirmed stereochemistry and enzymatic stability, highlighting their potential for therapeutic applications.
Katarzyna Jastrzębska, Patrycja Antończyk and Rafał Dolot
Org. Biomol. Chem., 2024,22, 8737-8742
Abstract
We present P-stereodefined morpholino phosphorothioate analogs and provide valuable structural insights into their stereochemistry. These P-diastereomerically pure analogs could have a significant impact in the field of nucleic acid therapeutics.
Jia-Bao Wang, Ji Yuan Lv, Siddheshwar Kisan Bankar, Shuai-Shuai Fang and Ming Shang
Chem. Soc. Rev., 2025,54, 9370-9406
Abstract
This review highlights recent advances in stereoselective synthesis of P-stereogenic nucleotide prodrugs and oligonucleotides, covering both chemical and enzymatic strategies.
Katarzyna Jastrzębska
RSC Adv., 2024,14, 21174-21179
From themed collection:
2024 RSC Advances Popular Advances Collection
Abstract
OTP method for the synthesis of P-stereodefined phosphorothioate has been extended to use activators TBD and Verkade base, which can be used interchangeably with DBU.
Chuo Chen
Org. Chem. Front., 2023,10, 1086-1098
From themed collection:
2023 Organic Chemistry Frontiers Review-type Articles
Abstract
This article describes how the synergy between chemistry and biology facilitated the development of cyclic dinucleotides as a potential new treatment for cancer.